Pharma companies are likely to sustain the healthy operating performance reported in the first quarter. The pharma companies cumulatively saw their pre-tax margins rising by 306 basis points (bps) on an annualised basis and 551 bps sequentially in the first quarter due to better prices and lower expenses both due to the lockdowns, according to a report by India Ratings on Monday.
Andrew Holland, CEO of Avendus Capital Alternate Strategies in an interview to CNBC-TV18, said he believes that the sector is in for a good run in the upcoming quarters too.
According to him, the pharma, healthcare sector has tailwinds for many years to come. He added that domestic travel, hotels will pick up in the next few months.Watch the video for more